tacrolimus and Encephalomyelitis

tacrolimus has been researched along with Encephalomyelitis* in 2 studies

Other Studies

2 other study(ies) available for tacrolimus and Encephalomyelitis

ArticleYear
Clinical, neuroradiological, diagnostic and prognostic profile of autoimmune glial fibrillary acidic protein astrocytopathy: A pooled analysis of 324 cases from published data and a single-center retrospective study.
    Journal of neuroimmunology, 2021, 11-15, Volume: 360

    Autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy is a recently defined autoimmune meningoencephalomyelitis, associated with GFAP-IgG antibody. A pooled analysis of 324 cases from published literature and a retrospective single-center study were performed, firstly reveals the possibility that patients with myelitic lesions respond better to initial immunotherapy, but are prone to relapse, suggesting a more aggressive and long-term immunosuppressive medication for them. Moreover, our results showed using tacrolimus at maintenance stage exhibited a less tendency to relapse, providing a possibly new choice to future clinical treatments.

    Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Astrocytes; Autoantigens; Autoimmune Diseases of the Nervous System; Child; Child, Preschool; China; Encephalomyelitis; Female; Follow-Up Studies; Glial Fibrillary Acidic Protein; Humans; Immunosuppressive Agents; Maintenance Chemotherapy; Male; Meningoencephalitis; Middle Aged; Prognosis; Recurrence; Retrospective Studies; Tacrolimus; Young Adult

2021
Clinically mild encephalitis/encephalopathy with a reversible splenial lesion associated with febrile urinary tract infection.
    European journal of pediatrics, 2014, Volume: 173, Issue:4

    Common pathogens of clinically mild encephalitis/encephalopathy with a reversible splenial lesion (MERS) are viruses, such as influenza virus. However, bacteria are rare pathogens for MERS. We report the first patient with MERS associated with febrile urinary tract infection. A 16-year-old lupus patient was admitted to our hospital. She had fever, headache, vomiting, and right back pain. Urinary analysis showed leukocyturia, and urinary culture identified Klebsiella pneumoniae. Cerebrospinal fluid examination and brain single-photon emission computed tomography showed no abnormalities. Therefore, she was diagnosed with febrile urinary tract infection. For further examinations, 99mTc-dimercaptosuccinic acid renal scintigraphy showed right cortical defects, and a voiding cystourethrogram demonstrated right vesicoureteral reflux (grade II). Therefore, she was diagnosed with right pyelonephritis. Although treatment with antibiotics administered intravenously improved the fever, laboratory findings, and right back pain, she had prolonged headaches, nausea, and vomiting. T2-weighted, diffusion-weighted, and fluid attenuated inversion recovery images in brain magnetic resonance imaging showed high intensity lesions in the splenium of the corpus callosum, which completely disappeared 1 week later. These results were compatible with MERS. To the best of our knowledge, our patient is the first patient who showed clinical features of MERS associated with febrile urinary tract infection.. In patients with pyelonephritis and an atypical clinical course, such as prolonged headache, nausea, vomiting, and neurological disorders, the possibility of MERS should be considered.

    Topics: Adolescent; Encephalomyelitis; Female; Fever; Glucocorticoids; Humans; Immunosuppressive Agents; Kidney; Klebsiella Infections; Klebsiella pneumoniae; Magnetic Resonance Imaging; Prednisolone; Pyelonephritis; Radionuclide Imaging; Radiopharmaceuticals; Tacrolimus; Technetium Tc 99m Dimercaptosuccinic Acid; Urinary Tract Infections

2014